{"id":339,"date":"2022-12-25T14:24:46","date_gmt":"2022-12-25T14:24:46","guid":{"rendered":"http:\/\/localhost\/tradedesk\/wordpress\/er-zealand-pharma-aktien-en-god-investering\/"},"modified":"2024-08-01T13:58:23","modified_gmt":"2024-08-01T13:58:23","slug":"er-zealand-pharma-aktien-en-god-investering","status":"publish","type":"post","link":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/","title":{"rendered":"Er Zealand Pharma aktien en god investering?"},"content":{"rendered":"\n<p><a href=\"https:\/\/tradedesk.dk\/blog\/wp-admin\/edit.php?post_type=post\"><\/a><\/p>\n\n\n\n<p>I dette indl\u00e6g vi p\u00e5 Zealand Pharma aktien og muligheder for at investere i aktien, som har udviklet sig meget positivt i 2024. Vi starter med at se p\u00e5 virksomheden, dens produkter og indtjening.<\/p>\n\n\n<p><span style=\"font-size: 18pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Hvad laver Zealand Pharma?<\/span><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Zealand Pharma er en international biotek virksomhed, der arbejder med udviklingen af nye l\u00e6gemidler til behandling af sygdomme inden for omr\u00e5derne diabetes, ford\u00f8jelsessystemet og kronisk tarmsygdom. Virksomheden har hoveds\u00e6de i K\u00f8benhavn, Danmark, og er noteret p\u00e5 NASDAQ K\u00f8benhavn. Zealand Pharma har en lang r\u00e6kke produkter i udvikling, herunder l\u00e6gemidler til behandling af diabetes, maves\u00e5r og andre ford\u00f8jelsessygdomme samt til behandling af kronisk tarmsygdom. Virksomheden samarbejder ogs\u00e5 med andre biotekvirksomheder og farmaceutiske selskaber om udviklingen af nye l\u00e6gemidler og terapier.<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 18pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Hvilke produkter f\u00f8rer Zealand Pharma?<\/span><\/p>\n<p><span style=\"background-color: transparent; color: #000000; font-family: Arial; font-size: 11pt; white-space: pre-wrap;\">Zealand Pharma har en lang r\u00e6kke produkter i udvikling, herunder l\u00e6gemidler til behandling af diabetes, maves\u00e5r og andre ford\u00f8jelsessygdomme samt til behandling af kronisk tarmsygdom. De har ogs\u00e5 nogle produkter, der allerede er godkendt til markedsf\u00f8ring og er tilg\u00e6ngelige p\u00e5 markedet.<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Eksempler p\u00e5 produkter, der allerede er godkendt til markedsf\u00f8ring, inkluderer:<\/span><b style=\"font-weight: normal;\"><\/b><\/p>\n<ul>\n<li style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Semaglutide: Et l\u00e6gemiddel til behandling af type 2-diabetes, der er tilg\u00e6ngeligt som en subkutan injektion.<\/span><\/li>\n<li><span style=\"background-color: transparent; color: #000000; font-family: Arial; font-size: 11pt; white-space: pre-wrap;\">Linaclotide: Et l\u00e6gemiddel til behandling af kronisk tarmsygdom, der er tilg\u00e6ngeligt som en oral kapsel.<\/span><\/li>\n<li><span style=\"background-color: transparent; color: #000000; font-family: Arial; font-size: 11pt; white-space: pre-wrap;\">Dasiglucagon: Et l\u00e6gemiddel til behandling af hypoglyk\u00e6mi (lavt blodsukker) hos patienter med diabetes, der er tilg\u00e6ngeligt som en subkutan injektion.<\/span><\/li>\n<\/ul>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Zealand Pharma har ogs\u00e5 flere produkter, der er i forskellige stadier af udvikling, inklusive l\u00e6gemidler til behandling af andre sygdomme inden for omr\u00e5derne diabetes, ford\u00f8jelsessystemet og kronisk tarmsygdom. Det er imidlertid vigtigt at bem\u00e6rke, at det ikke er sikkert, at alle disse produkter vil blive godkendt til markedsf\u00f8ring, da der er mange faktorer, der kan p\u00e5virke, om et l\u00e6gemiddel bliver godkendt af sundhedsmyndighederne.<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/tradedesk.imgix.net\/images\/6a5f5f879e7fa8e1bc25bf46a677c6e1.jpg\" \/><b style=\"font-weight: normal;\"><br \/><\/b><\/p>\n<p><b style=\"font-weight: normal;\"><br \/><\/b><span style=\"background-color: transparent; color: #000000; font-family: Arial; font-size: 18pt; white-space: pre-wrap;\">Tjener Zealand Pharma penge?<\/span><b style=\"font-weight: normal;\"><\/b><b style=\"font-weight: normal;\"><\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">If\u00f8lge Zealand Pharma&#8217;s \u00e5rsrapport for 2020 opn\u00e5ede virksomheden et nettoresultat p\u00e5 1,3 milliarder danske kroner (ca. 174 millioner dollar), hvilket var en stigning p\u00e5 knap 500 millioner danske kroner (ca. 67 millioner dollar) sammenlignet med \u00e5ret f\u00f8r. Virksomheden&#8217;s oms\u00e6tning for 2020 var p\u00e5 2,6 milliarder danske kroner (ca. 349 millioner dollar), hvilket ogs\u00e5 var en stigning sammenlignet med \u00e5ret f\u00f8r.<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Det er imidlertid vigtigt at huske, at Zealand Pharma&#8217;s \u00f8konomiske resultater kan variere fra \u00e5r til \u00e5r, og at de ikke n\u00f8dvendigvis vil v\u00e6re repr\u00e6sentative for fremtidige resultater.<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"margin-top: 0pt; margin-bottom: 0pt; line-height: 1.38;\"><span style=\"font-size: 18pt; font-family: Arial; color: #000000; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\">S\u00e5dan har aktien udviklet sig i 2022<\/span><\/p>\n<p dir=\"ltr\" style=\"margin-top: 0pt; margin-bottom: 0pt; line-height: 1.38;\"><img decoding=\"async\" src=\"https:\/\/tradedesk.imgix.net\/images\/51039b94cda460c6207f156bc240392b.jpg\" \/><span style=\"font-size: 18pt; font-family: Arial; color: #000000; background-color: transparent; font-variant-numeric: normal; font-variant-east-asian: normal; vertical-align: baseline; white-space: pre-wrap;\"><br \/><\/span><\/p>\n<div>\u00a0<\/div>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 18pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Hvem er Zealand Pharmas konkurrenter?<\/span><\/p>\n<p><span style=\"background-color: transparent; color: #000000; font-family: Arial; font-size: 11pt; white-space: pre-wrap;\">Der er mange andre virksomheder inden for l\u00e6gemiddelindustrien, der ogs\u00e5 arbejder med at udvikle l\u00e6gemidler til behandling af disse sygdomme, s\u00e5 det er sv\u00e6rt at n\u00e6vne alle Zealand Pharma&#8217;s konkurrenter.<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Nogle af de st\u00f8rste biotekvirksomheder, der arbejder med at udvikle l\u00e6gemidler inden for omr\u00e5derne diabetes, ford\u00f8jelsessystemet og kronisk tarmsygdom, inkluderer:<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<ul>\n<li style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Novo Nordisk<\/span><\/li>\n<li style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Sanofi<\/span><\/li>\n<li style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Eli Lilly<\/span><\/li>\n<li style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Roche<\/span><\/li>\n<li style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">AstraZeneca<\/span><\/li>\n<\/ul>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Det er imidlertid vigtigt at huske, at der ogs\u00e5 er mange andre mindre biotekvirksomheder og farmaceutiske selskaber, der arbejder med at udvikle l\u00e6gemidler inden for disse omr\u00e5der og derfor ogs\u00e5 kan v\u00e6re konkurrenter for Zealand Pharma. <\/span><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">\u00a0<\/span><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Derudover kan virksomheder inden for andre industrier, s\u00e5som teknologi- og sundhedsteknologivirksomheder, ogs\u00e5 v\u00e6re konkurrenter for Zealand Pharma, hvis de begynder at udvikle l\u00e6gemidler eller terapier inden for de samme omr\u00e5der.<\/span><\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 18pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Hvilke risikofaktorer er der ved en investering i Zealand Pharma aktien?<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Der er en r\u00e6kke risikofaktorer, som kan p\u00e5virke Zealand Pharma&#8217;s forretning og \u00f8konomiske resultater. Nogle af de mest almindelige risikofaktorer for biotekvirksomheder inkluderer:<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Udviklingen af l\u00e6gemidler tager lang tid og kan v\u00e6re meget kostbart. Der er ingen garanti for, at et l\u00e6gemiddel, der er i udvikling, vil blive godkendt til markedsf\u00f8ring, og derfor kan mange \u00e5rs og mange millioner kroners investeringer g\u00e5 tabt.<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Der er stor konkurrence inden for l\u00e6gemiddelindustrien, og det kan v\u00e6re sv\u00e6rt for Zealand Pharma at skille sig ud fra konkurrenterne.<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Zealand Pharma er afh\u00e6ngig af licensaftaler med andre selskaber for at markedsf\u00f8re og distribuere deres produkter. S\u00e5danne aftaler kan opsiges eller \u00e6ndres, hvilket kan p\u00e5virke virksomhedens salg og indtjening.<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">L\u00e6gemiddelindustrien er underlagt strenge reguleringer fra sundhedsmyndigheder, og Zealand Pharma kan blive udsat for sanktioner eller b\u00f8der, hvis de ikke overholder reglerne.<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Zealand Pharma er afh\u00e6ngig af patentbeskyttelse for at beskytte deres l\u00e6gemidler og teknologier. Hvis deres patenter ikke fornyes eller udl\u00f8ber, kan det p\u00e5virke virksomhedens indtjening.<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">\u00c6ndringer i valutakurser kan p\u00e5virke Zealand Pharma&#8217;s indtjening, da virksomheden har forretninger i mange forskellige lande.<\/span><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Der er ingen garanti for, at Zealand Pharma&#8217;s produkter vil blive godt modtaget af kunderne eller at de vil opleve stor eftersp\u00f8rgsel.<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Det er vigtigt at huske, at disse risikofaktorer er generelle og kan p\u00e5virke mange biotekvirksomheder. Det er altid en god id\u00e9 at unders\u00f8ge de specifikke risikofaktorer, der kan p\u00e5virke en given virksomhed, f\u00f8r man investerer i den.<\/span><\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 18pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Hvor kan jeg handle aktien?<\/span><\/p>\n<p><b style=\"font-weight: normal;\">\u00a0<\/b><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Zealand Pharma&#8217;s aktier er noteret p\u00e5 NASDAQ K\u00f8benhavn, som er en af de st\u00f8rste b\u00f8rser i Danmark. Det betyder, at du kan handle aktier i Zealand Pharma p\u00e5 NASDAQ K\u00f8benhavn, hvis du \u00f8nsker at investere i virksomheden.<\/span><\/p>\n<p dir=\"ltr\" style=\"line-height: 1.38; margin-top: 0pt; margin-bottom: 0pt;\"><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">Der findes mange m\u00e5der, hvorp\u00e5 du kan handle aktier p\u00e5 NASDAQ K\u00f8benhavn eller andre b\u00f8rser. Du kan f.eks. handle aktier gennem en online m\u00e6gler eller en bank, der tilbyder investeringsprodukter. Du kan ogs\u00e5 v\u00e6lge at handle aktier gennem en traditionel m\u00e6gler, der kan give dig r\u00e5dgivning om, hvilke aktier du skal k\u00f8be eller s\u00e6lge.<br \/><br \/>L\u00e6s mere om Zealand Pharma aktien her:<\/span><span style=\"font-size: 11pt; font-family: Arial; color: #000000; background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;\">https:\/\/www.zealandpharma.com\/investor\/investor-relations\/<br \/><\/span><\/p>\n<p dir=\"ltr\">\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p>Zealand Pharma aktien er steget kraftigt i 2022, efter at have v\u00e6ret en sl\u00f8v investering i \u00e5revis. Vi har taget et kig p\u00e5 aktien her og p\u00e5 hvad virksomheden laver.<\/p>\n","protected":false},"author":4,"featured_media":365,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[47,1],"tags":[],"class_list":["post-339","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aktie-analyse","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Zealand Pharma Aktien: Et brag af en investering - Aktien i ATH &#8212; TradeDesk<\/title>\n<meta name=\"description\" content=\"L\u00e6r om Zealand Pharma aktien og deres innovative l\u00e6gemidler til behandling af diabetes, ford\u00f8jelsessygdomme og tarmsygdomme.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/\" \/>\n<meta property=\"og:locale\" content=\"da_DK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Er Zealand Pharma aktien en god investering?\" \/>\n<meta property=\"og:description\" content=\"L\u00e6r om Zealand Pharma aktien og deres innovative l\u00e6gemidler til behandling af diabetes, ford\u00f8jelsessygdomme og tarmsygdomme.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/\" \/>\n<meta property=\"og:site_name\" content=\"TradeDesk\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/groups\/Aktiebosserne\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/mr.tradedesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-25T14:24:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-01T13:58:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradedesk.dk\/blog\/wp-content\/uploads\/2022\/12\/aaaa.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1340\" \/>\n\t<meta property=\"og:image:height\" content=\"497\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Troels H\u00f8jbjerg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet af\" \/>\n\t<meta name=\"twitter:data1\" content=\"Troels H\u00f8jbjerg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimeret l\u00e6setid\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/er-zealand-pharma-aktien-en-god-investering\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/er-zealand-pharma-aktien-en-god-investering\\\/\"},\"author\":{\"name\":\"Troels H\u00f8jbjerg\",\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/#\\\/schema\\\/person\\\/11b5219f5dd347c4c62e36213456edc6\"},\"headline\":\"Er Zealand Pharma aktien en god investering?\",\"datePublished\":\"2022-12-25T14:24:46+00:00\",\"dateModified\":\"2024-08-01T13:58:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/er-zealand-pharma-aktien-en-god-investering\\\/\"},\"wordCount\":971,\"publisher\":{\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/er-zealand-pharma-aktien-en-god-investering\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/aaaa.png\",\"articleSection\":[\"Aktie Analyse\",\"News\"],\"inLanguage\":\"da-DK\",\"copyrightYear\":\"2022\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/er-zealand-pharma-aktien-en-god-investering\\\/\",\"url\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/er-zealand-pharma-aktien-en-god-investering\\\/\",\"name\":\"Zealand Pharma Aktien: Et brag af en investering - Aktien i ATH &#8212; TradeDesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/er-zealand-pharma-aktien-en-god-investering\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/er-zealand-pharma-aktien-en-god-investering\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/aaaa.png\",\"datePublished\":\"2022-12-25T14:24:46+00:00\",\"dateModified\":\"2024-08-01T13:58:23+00:00\",\"description\":\"L\u00e6r om Zealand Pharma aktien og deres innovative l\u00e6gemidler til behandling af diabetes, ford\u00f8jelsessygdomme og tarmsygdomme.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/er-zealand-pharma-aktien-en-god-investering\\\/#breadcrumb\"},\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/er-zealand-pharma-aktien-en-god-investering\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/er-zealand-pharma-aktien-en-god-investering\\\/#primaryimage\",\"url\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/aaaa.png\",\"contentUrl\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/wp-content\\\/uploads\\\/2022\\\/12\\\/aaaa.png\",\"width\":1340,\"height\":497},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/er-zealand-pharma-aktien-en-god-investering\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Er Zealand Pharma aktien en god investering?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/\",\"name\":\"TradeDesk\",\"description\":\"Aktier og Investering\",\"publisher\":{\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"da-DK\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/#organization\",\"name\":\"TradeDesk\",\"url\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/tradedesk_logo.png\",\"contentUrl\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/tradedesk_logo.png\",\"width\":140,\"height\":160,\"caption\":\"TradeDesk\"},\"image\":{\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/groups\\\/Aktiebosserne\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/#\\\/schema\\\/person\\\/11b5219f5dd347c4c62e36213456edc6\",\"name\":\"Troels H\u00f8jbjerg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/711278690339fa5b629878682802934b929d741bad542c7cc3b980fd946b37ca?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/711278690339fa5b629878682802934b929d741bad542c7cc3b980fd946b37ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/711278690339fa5b629878682802934b929d741bad542c7cc3b980fd946b37ca?s=96&d=mm&r=g\",\"caption\":\"Troels H\u00f8jbjerg\"},\"description\":\"Jeg hedder Troels H\u00f8jbjerg og er direkt\u00f8r for TradeDesk. Jeg har en cand.merc. i innovation og management, og jeg har mange \u00e5rs erfaring inden for aktiehandel og investering. Med min akademiske baggrund har jeg opbygget en solid forst\u00e5else af markedsdynamikker og specialiseret mig i teknisk analyse og evidensbaserede strategier. Min karriere begyndte som portef\u00f8ljemanager hos Markedskraft, hvor jeg arbejdede med trading og prismodellering af elpriser. Denne erfaring t\u00e6ndte min interesse for teknisk analyse, is\u00e6r n\u00e5r det g\u00e6lder aktiemarkedet, hvor jeg har stor viden om candlestick diagrammer. Jeg har l\u00e6st mange anerkendte b\u00f8ger inden for feltet, herunder \\\"What Works on Wall Street,\\\" \\\"Encyclopedia of Candlesticks,\\\" \\\"Encyclopedia of Chart Patterns,\\\" og \\\"Trading in the Zone.\\\" Jeg er medlem og abonnent af Dansk Aktion\u00e6rforening og Stocks &amp; Commodities, og jeg har holdt foredrag for IDA (Dansk Aktion\u00e6rforening), FOF og har fungeret som mentor for danske investorer siden 2018. I 2016 grundlagde jeg TradeDesk, hvor jeg udviklede min egen trading software til at scanne aktiemarkedet for vendinger i aktier ved hj\u00e6lp af candlestick diagrammer. Siden 2015 har jeg fulgt markedet t\u00e6t og navigeret gennem udfordrende perioder som krigen i Ukraine, energikriser, corona-pandemien og inflationspr\u00e6gede markeder. Min trading stil kombinerer trendfollowing og swingtrading, underst\u00f8ttet af grundl\u00e6ggende analyser. Min omfattende erfaring og dybdeg\u00e5ende viden g\u00f8r mig til en autoritet inden for aktiehandel og investering, og jeg har hjulpet mange investorer med at opn\u00e5 bedre resultater p\u00e5 aktiemarkedet. For mere information om mig og mit arbejde, bes\u00f8g TradeDesk. Du kan ogs\u00e5 finde mig p\u00e5 YouTube og LinkedIn. Du kan kontakte mig p\u00e5 troels@tradedesk.dk.\",\"sameAs\":[\"https:\\\/\\\/www.tradedesk.dk\",\"https:\\\/\\\/www.facebook.com\\\/mr.tradedesk\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/mrtradedesk\\\/\",\"http:\\\/\\\/www.youtube.com\\\/@TroelsHjbjerg\"],\"honorificPrefix\":\"Hr.\",\"honorificSuffix\":\"Direkt\u00f8r, Cand. Merc.\",\"birthDate\":\"1982-01-15\",\"gender\":\"mand\",\"award\":[\"Selvst\u00e6ndig\"],\"knowsAbout\":[\"Teknisk analyse\",\"Aktieanalyse\"],\"knowsLanguage\":[\"dansk\",\"engelsk\"],\"jobTitle\":\"Direkt\u00f8r og aktieanalytiker\",\"worksFor\":\"TradeDesk Aps\",\"url\":\"https:\\\/\\\/tradedesk.dk\\\/blog\\\/author\\\/troels\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Zealand Pharma Aktien: Et brag af en investering - Aktien i ATH &#8212; TradeDesk","description":"L\u00e6r om Zealand Pharma aktien og deres innovative l\u00e6gemidler til behandling af diabetes, ford\u00f8jelsessygdomme og tarmsygdomme.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/","og_locale":"da_DK","og_type":"article","og_title":"Er Zealand Pharma aktien en god investering?","og_description":"L\u00e6r om Zealand Pharma aktien og deres innovative l\u00e6gemidler til behandling af diabetes, ford\u00f8jelsessygdomme og tarmsygdomme.","og_url":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/","og_site_name":"TradeDesk","article_publisher":"https:\/\/www.facebook.com\/groups\/Aktiebosserne","article_author":"https:\/\/www.facebook.com\/mr.tradedesk","article_published_time":"2022-12-25T14:24:46+00:00","article_modified_time":"2024-08-01T13:58:23+00:00","og_image":[{"width":1340,"height":497,"url":"https:\/\/tradedesk.dk\/blog\/wp-content\/uploads\/2022\/12\/aaaa.png","type":"image\/png"}],"author":"Troels H\u00f8jbjerg","twitter_card":"summary_large_image","twitter_misc":{"Skrevet af":"Troels H\u00f8jbjerg","Estimeret l\u00e6setid":"6 minutter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/#article","isPartOf":{"@id":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/"},"author":{"name":"Troels H\u00f8jbjerg","@id":"https:\/\/tradedesk.dk\/blog\/#\/schema\/person\/11b5219f5dd347c4c62e36213456edc6"},"headline":"Er Zealand Pharma aktien en god investering?","datePublished":"2022-12-25T14:24:46+00:00","dateModified":"2024-08-01T13:58:23+00:00","mainEntityOfPage":{"@id":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/"},"wordCount":971,"publisher":{"@id":"https:\/\/tradedesk.dk\/blog\/#organization"},"image":{"@id":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/#primaryimage"},"thumbnailUrl":"https:\/\/tradedesk.dk\/blog\/wp-content\/uploads\/2022\/12\/aaaa.png","articleSection":["Aktie Analyse","News"],"inLanguage":"da-DK","copyrightYear":"2022","copyrightHolder":{"@id":"https:\/\/tradedesk.dk\/blog\/#organization"}},{"@type":"WebPage","@id":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/","url":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/","name":"Zealand Pharma Aktien: Et brag af en investering - Aktien i ATH &#8212; TradeDesk","isPartOf":{"@id":"https:\/\/tradedesk.dk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/#primaryimage"},"image":{"@id":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/#primaryimage"},"thumbnailUrl":"https:\/\/tradedesk.dk\/blog\/wp-content\/uploads\/2022\/12\/aaaa.png","datePublished":"2022-12-25T14:24:46+00:00","dateModified":"2024-08-01T13:58:23+00:00","description":"L\u00e6r om Zealand Pharma aktien og deres innovative l\u00e6gemidler til behandling af diabetes, ford\u00f8jelsessygdomme og tarmsygdomme.","breadcrumb":{"@id":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/#breadcrumb"},"inLanguage":"da-DK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/"]}]},{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/#primaryimage","url":"https:\/\/tradedesk.dk\/blog\/wp-content\/uploads\/2022\/12\/aaaa.png","contentUrl":"https:\/\/tradedesk.dk\/blog\/wp-content\/uploads\/2022\/12\/aaaa.png","width":1340,"height":497},{"@type":"BreadcrumbList","@id":"https:\/\/tradedesk.dk\/blog\/er-zealand-pharma-aktien-en-god-investering\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradedesk.dk\/blog\/"},{"@type":"ListItem","position":2,"name":"Er Zealand Pharma aktien en god investering?"}]},{"@type":"WebSite","@id":"https:\/\/tradedesk.dk\/blog\/#website","url":"https:\/\/tradedesk.dk\/blog\/","name":"TradeDesk","description":"Aktier og Investering","publisher":{"@id":"https:\/\/tradedesk.dk\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradedesk.dk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"da-DK"},{"@type":"Organization","@id":"https:\/\/tradedesk.dk\/blog\/#organization","name":"TradeDesk","url":"https:\/\/tradedesk.dk\/blog\/","logo":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/tradedesk.dk\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/tradedesk_logo.png","contentUrl":"https:\/\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/tradedesk_logo.png","width":140,"height":160,"caption":"TradeDesk"},"image":{"@id":"https:\/\/tradedesk.dk\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/groups\/Aktiebosserne"]},{"@type":"Person","@id":"https:\/\/tradedesk.dk\/blog\/#\/schema\/person\/11b5219f5dd347c4c62e36213456edc6","name":"Troels H\u00f8jbjerg","image":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/secure.gravatar.com\/avatar\/711278690339fa5b629878682802934b929d741bad542c7cc3b980fd946b37ca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/711278690339fa5b629878682802934b929d741bad542c7cc3b980fd946b37ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/711278690339fa5b629878682802934b929d741bad542c7cc3b980fd946b37ca?s=96&d=mm&r=g","caption":"Troels H\u00f8jbjerg"},"description":"Jeg hedder Troels H\u00f8jbjerg og er direkt\u00f8r for TradeDesk. Jeg har en cand.merc. i innovation og management, og jeg har mange \u00e5rs erfaring inden for aktiehandel og investering. Med min akademiske baggrund har jeg opbygget en solid forst\u00e5else af markedsdynamikker og specialiseret mig i teknisk analyse og evidensbaserede strategier. Min karriere begyndte som portef\u00f8ljemanager hos Markedskraft, hvor jeg arbejdede med trading og prismodellering af elpriser. Denne erfaring t\u00e6ndte min interesse for teknisk analyse, is\u00e6r n\u00e5r det g\u00e6lder aktiemarkedet, hvor jeg har stor viden om candlestick diagrammer. Jeg har l\u00e6st mange anerkendte b\u00f8ger inden for feltet, herunder \"What Works on Wall Street,\" \"Encyclopedia of Candlesticks,\" \"Encyclopedia of Chart Patterns,\" og \"Trading in the Zone.\" Jeg er medlem og abonnent af Dansk Aktion\u00e6rforening og Stocks &amp; Commodities, og jeg har holdt foredrag for IDA (Dansk Aktion\u00e6rforening), FOF og har fungeret som mentor for danske investorer siden 2018. I 2016 grundlagde jeg TradeDesk, hvor jeg udviklede min egen trading software til at scanne aktiemarkedet for vendinger i aktier ved hj\u00e6lp af candlestick diagrammer. Siden 2015 har jeg fulgt markedet t\u00e6t og navigeret gennem udfordrende perioder som krigen i Ukraine, energikriser, corona-pandemien og inflationspr\u00e6gede markeder. Min trading stil kombinerer trendfollowing og swingtrading, underst\u00f8ttet af grundl\u00e6ggende analyser. Min omfattende erfaring og dybdeg\u00e5ende viden g\u00f8r mig til en autoritet inden for aktiehandel og investering, og jeg har hjulpet mange investorer med at opn\u00e5 bedre resultater p\u00e5 aktiemarkedet. For mere information om mig og mit arbejde, bes\u00f8g TradeDesk. Du kan ogs\u00e5 finde mig p\u00e5 YouTube og LinkedIn. Du kan kontakte mig p\u00e5 troels@tradedesk.dk.","sameAs":["https:\/\/www.tradedesk.dk","https:\/\/www.facebook.com\/mr.tradedesk","https:\/\/www.linkedin.com\/in\/mrtradedesk\/","http:\/\/www.youtube.com\/@TroelsHjbjerg"],"honorificPrefix":"Hr.","honorificSuffix":"Direkt\u00f8r, Cand. Merc.","birthDate":"1982-01-15","gender":"mand","award":["Selvst\u00e6ndig"],"knowsAbout":["Teknisk analyse","Aktieanalyse"],"knowsLanguage":["dansk","engelsk"],"jobTitle":"Direkt\u00f8r og aktieanalytiker","worksFor":"TradeDesk Aps","url":"https:\/\/tradedesk.dk\/blog\/author\/troels\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/tradedesk.dk\/blog\/wp-content\/uploads\/2022\/12\/aaaa.png","jetpack-related-posts":[{"id":1559,"url":"https:\/\/tradedesk.dk\/blog\/uge-26-novo-nordisk-aktien-zealand-pharma-aktie-flyver-og-bavarian-kommer-med-gode-aktie-nyheder\/","url_meta":{"origin":339,"position":0},"title":"Uge 26: Novo Nordisk nedskriver, Zealand Pharma flyver og Bavarian kommer med gode nyheder.","author":"Troels H\u00f8jbjerg","date":"2024-06-28","format":false,"excerpt":"Vi ser p\u00e5 3 aktienyheder, som specielt var interessant for danske investorer nemlig nyheder fra Novo Nordisk, Zealand Pharma og Bavarian Nordic. B\u00e5de Zealand Pharma og Novo Nordisk aktierne har v\u00e6ret fantastiske investeringer i \u00e5r. Lidt mere blandet er det med Bavarian Nordic, hvor aktien ikke helt er kommet i\u2026","rel":"","context":"In &quot;Danske aktier&quot;","block_context":{"text":"Danske aktier","link":"https:\/\/tradedesk.dk\/blog\/category\/danske-aktier\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/10358975-cf21-4f74-bc5e-b4f92c443175.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/10358975-cf21-4f74-bc5e-b4f92c443175.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/10358975-cf21-4f74-bc5e-b4f92c443175.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/10358975-cf21-4f74-bc5e-b4f92c443175.webp?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/10358975-cf21-4f74-bc5e-b4f92c443175.webp?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":1462,"url":"https:\/\/tradedesk.dk\/blog\/momentum-falder-i-tech-aktier-groenne-aktier-er-billige\/","url_meta":{"origin":339,"position":1},"title":"Uge 25: Momentum falder i tech aktier, Gr\u00f8nne aktier er billige og Zealand Pharma kommer med gode resultater.","author":"Troels H\u00f8jbjerg","date":"2024-06-25","format":false,"excerpt":"Momentum i AI og tech er faldende, men bliver det til mere end en korrektion? Saxo Banks Oskar tror p\u00e5 Gr\u00f8n energi og Sol, som har v\u00e6ret lavt prissat. Zealand Pharma kommer med gode resultater og aktiekursen sk\u00f8d i vejret.","rel":"","context":"In &quot;Danske aktier&quot;","block_context":{"text":"Danske aktier","link":"https:\/\/tradedesk.dk\/blog\/category\/danske-aktier\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/741679d8-a933-4ca2-b75b-bbee5adf989d.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/741679d8-a933-4ca2-b75b-bbee5adf989d.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/741679d8-a933-4ca2-b75b-bbee5adf989d.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/741679d8-a933-4ca2-b75b-bbee5adf989d.webp?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/741679d8-a933-4ca2-b75b-bbee5adf989d.webp?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":1890,"url":"https:\/\/tradedesk.dk\/blog\/hvordan-paavirker-den-staerke-amerikanske-jobrapport-danske-aktier-og-sektorer\/","url_meta":{"origin":339,"position":2},"title":"Hvordan p\u00e5virker den st\u00e6rke amerikanske jobrapport danske aktier og sektorer?","author":"Troels H\u00f8jbjerg","date":"2024-10-07","format":false,"excerpt":"Fredagens st\u00e6rkere end forventede amerikanske jobrapport har haft en betydelig indvirkning p\u00e5 b\u00e5de de globale og danske aktiemarkeder. De nye tal fra USA viser, at arbejdsmarkedet er robust, hvilket har justeret markedets forventninger til fremtidige renteneds\u00e6ttelser.","rel":"","context":"In &quot;Danske aktier&quot;","block_context":{"text":"Danske aktier","link":"https:\/\/tradedesk.dk\/blog\/category\/danske-aktier\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/10\/e0c34625-32a2-4ac8-99ab-5e06d9f717a7.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/10\/e0c34625-32a2-4ac8-99ab-5e06d9f717a7.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/10\/e0c34625-32a2-4ac8-99ab-5e06d9f717a7.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/10\/e0c34625-32a2-4ac8-99ab-5e06d9f717a7.webp?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/10\/e0c34625-32a2-4ac8-99ab-5e06d9f717a7.webp?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":1850,"url":"https:\/\/tradedesk.dk\/blog\/c25-indeks-falder-investorer-foelger-centralbankernes-politik\/","url_meta":{"origin":339,"position":3},"title":"C25-indeks falder: Investorer f\u00f8lger centralbankernes politik","author":"Troels H\u00f8jbjerg","date":"2024-10-02","format":false,"excerpt":"Negativ stemning og fald i det danske indeks p\u00e5 knap 3%.Svage industri indikatorer fra b\u00e5de Europa og USA har trukket det danske C25-indeks ned. Globalt har investorerne fulgt t\u00e6t med i udtalelser fra centralbankerne, is\u00e6r Federal Reserve og ECB, hvor der er fokus p\u00e5 kommende rentes\u00e6nkninger og at opn\u00e5 en\u2026","rel":"","context":"In &quot;News&quot;","block_context":{"text":"News","link":"https:\/\/tradedesk.dk\/blog\/category\/news\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/10\/57a4ce81-ae49-479d-8c22-10eb4136ac9f.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/10\/57a4ce81-ae49-479d-8c22-10eb4136ac9f.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/10\/57a4ce81-ae49-479d-8c22-10eb4136ac9f.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/10\/57a4ce81-ae49-479d-8c22-10eb4136ac9f.webp?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/10\/57a4ce81-ae49-479d-8c22-10eb4136ac9f.webp?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":1370,"url":"https:\/\/tradedesk.dk\/blog\/uge-34-i-aktiemarkedet-inflationen-falder-i-usa-og-renten-holdes-af-fed\/","url_meta":{"origin":339,"position":4},"title":"Uge 24 i aktiemarkedet: Inflationen falder i USA og renten holdes af FED","author":"Troels H\u00f8jbjerg","date":"2024-06-21","format":false,"excerpt":"Inflationen faldt i USA, men renten holdes u\u00e6ndret af FED, hvad betyder det for aktiemarkedet og dine aktier?","rel":"","context":"In &quot;Danske aktier&quot;","block_context":{"text":"Danske aktier","link":"https:\/\/tradedesk.dk\/blog\/category\/danske-aktier\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/infaltionen-falder-scaled.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/infaltionen-falder-scaled.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/infaltionen-falder-scaled.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/infaltionen-falder-scaled.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/infaltionen-falder-scaled.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/06\/infaltionen-falder-scaled.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":1734,"url":"https:\/\/tradedesk.dk\/blog\/ugens-aktie-nyheder-derfor-falder-teknologi-aktierne\/","url_meta":{"origin":339,"position":5},"title":"Aktie Nyheder: Derfor falder teknologi aktierne &#8211; selvom renten skal ned?","author":"Troels H\u00f8jbjerg","date":"2024-07-12","format":false,"excerpt":"Denne uge i aktiemarkedet har v\u00e6ret pr\u00e6get af: Profittagning og virksomhedsspecifikke nyheder, som har sendt sendt markedet i r\u00f8dt. Det ligner, lige nu, en sektorrotation mod ejendomme og forsyningsselskaber (lavere rente forventninger). Derfor er investorerne nu blevet en smule usikre og der s\u00e6lges ud i stor stil af de mest\u2026","rel":"","context":"In &quot;Danske aktier&quot;","block_context":{"text":"Danske aktier","link":"https:\/\/tradedesk.dk\/blog\/category\/danske-aktier\/"},"img":{"alt_text":"Aktierne falder - her er 5 grunde til det sker.","src":"https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/07\/Derfor-falder-aktierne-nyheder-og-analyser.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/07\/Derfor-falder-aktierne-nyheder-og-analyser.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/07\/Derfor-falder-aktierne-nyheder-og-analyser.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/07\/Derfor-falder-aktierne-nyheder-og-analyser.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/07\/Derfor-falder-aktierne-nyheder-og-analyser.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/tradedesk.dk\/blog\/wp-content\/uploads\/2024\/07\/Derfor-falder-aktierne-nyheder-og-analyser.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pfSnVH-5t","_links":{"self":[{"href":"https:\/\/tradedesk.dk\/blog\/wp-json\/wp\/v2\/posts\/339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradedesk.dk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradedesk.dk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradedesk.dk\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/tradedesk.dk\/blog\/wp-json\/wp\/v2\/comments?post=339"}],"version-history":[{"count":7,"href":"https:\/\/tradedesk.dk\/blog\/wp-json\/wp\/v2\/posts\/339\/revisions"}],"predecessor-version":[{"id":1798,"href":"https:\/\/tradedesk.dk\/blog\/wp-json\/wp\/v2\/posts\/339\/revisions\/1798"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradedesk.dk\/blog\/wp-json\/wp\/v2\/media\/365"}],"wp:attachment":[{"href":"https:\/\/tradedesk.dk\/blog\/wp-json\/wp\/v2\/media?parent=339"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradedesk.dk\/blog\/wp-json\/wp\/v2\/categories?post=339"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradedesk.dk\/blog\/wp-json\/wp\/v2\/tags?post=339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}